Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID | UniProt ID | Title | Descriptor ▼ |
|---|---|---|---|
| 8VYE | P0DTC2 | SARS-CoV-2 S (C.37 Lambda variant) plus S309, S2L20, and S2X303 Fabs | |
| 8VYF | P0DTC2 | SARS-CoV-2 S NTD (C.37 Lambda variant) plus S2L20 and S2X303 Fabs, local refinement | |
| 8VYF | 8VYF | SARS-CoV-2 S NTD (C.37 Lambda variant) plus S2L20 and S2X303 Fabs, local refinement | |
| 8VYG | 8VYG | SARS-CoV-2 S RBD (C.37 Lambda variant) plus S309 Fab, local refinement | |
| 8VYG | P0DTC2 | SARS-CoV-2 S RBD (C.37 Lambda variant) plus S309 Fab, local refinement | |
| 8W0V | A0A2P0NE15 | Crystal structure of broadly neutralizing antibody hcab55 in complex with Hepatitis C virus envelope glycoprotein E2 ectodomain | |
| 8W0V | 8W0V | Crystal structure of broadly neutralizing antibody hcab55 in complex with Hepatitis C virus envelope glycoprotein E2 ectodomain | |
| 8W0W | A0A2P0NE15 | Crystal structure of broadly neutralizing antibody hcab64 in complex with Hepatitis C virus envelope glycoprotein E2 ectodomain | |
| 8W0W | 8W0W | Crystal structure of broadly neutralizing antibody hcab64 in complex with Hepatitis C virus envelope glycoprotein E2 ectodomain | |
| 8W0X | A0A2P0NE15 | Crystal structure of broadly neutralizing antibody hcab40 in complex with Hepatitis C virus envelope glycoprotein E2 ectodomain | |
| 8W0X | 8W0X | Crystal structure of broadly neutralizing antibody hcab40 in complex with Hepatitis C virus envelope glycoprotein E2 ectodomain | |
| 8W0Y | 8W0Y | Crystal structure of broadly neutralizing antibody hcab17 in complex with Hepatitis C virus envelope glycoprotein E2 ectodomain | |
| 8W0Y | A0A2P0NE15 | Crystal structure of broadly neutralizing antibody hcab17 in complex with Hepatitis C virus envelope glycoprotein E2 ectodomain | |
| 8WLO | P0DTC2 | Cryo-EM structure of SARS-CoV-2 prototype spike protein in complex with hippopotamus ACE2 | |
| 8WLO | 8WLO | Cryo-EM structure of SARS-CoV-2 prototype spike protein in complex with hippopotamus ACE2 | |
| 8WLR | 8WLR | Cryo-EM structure of SARS-CoV-2 prototype spike protein receptor-binding domain in complex with hippopotamus ACE2 | |
| 8WLR | P0DTC2 | Cryo-EM structure of SARS-CoV-2 prototype spike protein receptor-binding domain in complex with hippopotamus ACE2 | |
| 8F2X | P0DTC2 | Crystal structure of antibody WRAIR-2123 in complex with SARS-CoV-2 receptor binding domain | |
| 8F2X | 8F2X | Crystal structure of antibody WRAIR-2123 in complex with SARS-CoV-2 receptor binding domain | |
| 8GYO | Q96RD7 | Inner channel lipids regulated gating mechanism of human pannexins. | |
| 8GYP | Q96QZ0 | Cryo-EM structure of human Pannexin-3 in closed state. | |
| 8GYQ | Q96RD6 | Cryo-EM structure of human Pannexin-2 in pre-open state. | |
| 8GYT | Q96QZ0 | Cryo-EM structure of human Pannexin-3 R36S/F40R variant in pre-open state. | |
| 8JEX | P37840 | Cryo-EM structure of alpha-synuclein gS87 fibril | |
| 8JEX | 8JEX | Cryo-EM structure of alpha-synuclein gS87 fibril | |
| 8JH8 | 8JH8 | Structure-based characterization and improvement of an enzymatic activity of Acremonium alcalophilum feruloyl esterase | |
| 8JH9 | 8JH9 | Structure-based characterization and improvement of an enzymatic activity of Acremonium alcalophilum feruloyl esterase | |
| 8JZB | 8JZB | Langya Henipavirus attachment protein | |
| 8KHC | P0DTC2 | SARS-CoV-2 Omicron spike in complex with 5817 Fab | |
| 8KHC | 8KHC | SARS-CoV-2 Omicron spike in complex with 5817 Fab | |
| 8KHD | P0DTC2 | The interface structure of Omicron RBD binding to 5817 Fab | |
| 8KHD | 8KHD | The interface structure of Omicron RBD binding to 5817 Fab | |
| 8Q5U | Q6MZV7 | Endoglycosidase S2 in complex with IgG1 Fc | |
| 8Q5U | A0A8H2N1T2 | Endoglycosidase S2 in complex with IgG1 Fc | |
| 8RHI | A0A0C7CWY9 | Lytic Transglycosylase MltD of Pseudomonas aeruginosa in a ternary complex bound to Bulgecin A and chito-tetraose | |
| 8SGA | 8SGA | Crystal structure of 770E11, a monoclonal antibody isolated from a human Epstein-Barr virus seropositive donor | |
| 8SGN | P03200 | Crystal structure of Epstein-Barr virus glycoprotein 350 (gp350) in complex with Cy651H02, a monoclonal antibody isolated from macaques immunized with a gp350 nanoparticle vaccine | |
| 8SGN | 8SGN | Crystal structure of Epstein-Barr virus glycoprotein 350 (gp350) in complex with Cy651H02, a monoclonal antibody isolated from macaques immunized with a gp350 nanoparticle vaccine | |
| 8SIC | 8SIC | Crystal structure of Epstein-Barr virus glycoprotein 350 (gp350) in complex with Cy137C02, a monoclonal antibody isolated from macaques immunized with a gp350 nanoparticle vaccine | |
| 8SIC | P03200 | Crystal structure of Epstein-Barr virus glycoprotein 350 (gp350) in complex with Cy137C02, a monoclonal antibody isolated from macaques immunized with a gp350 nanoparticle vaccine | |
| 8TFH | P02879 | Ricin in complex with Fab JB4 | |
| 8TFH | 8TFH | Ricin in complex with Fab JB4 | |
| 8TFL | P02879 | Ricin in complex with Fab SylH3 | |
| 8TFL | 8TFL | Ricin in complex with Fab SylH3 | |
| 8TGO | Q2N0S6 | Crystal structure of the BG505 triple tandem trimer gp140 HIV-1 Env in complex with PGT124 and 35O22 | |
| 8TGO | 8TGO | Crystal structure of the BG505 triple tandem trimer gp140 HIV-1 Env in complex with PGT124 and 35O22 | |
| 8TLZ | Q29983 | Preclinical Characterization of Pan-NKG2D Ligand-Binding NKG2D Receptor Decoys | |
| 8TM0 | P26718 | Preclinical Characterization of Pan-NKG2D Ligand-Binding NKG2D Receptor Decoys | |
| 8TM0 | Q29983 | Preclinical Characterization of Pan-NKG2D Ligand-Binding NKG2D Receptor Decoys | |
| 8TM2 | P26718 | Preclinical Characterization of Pan-NKG2D Ligand-Binding NKG2D Receptor Decoys |
